Ching-Yi Chang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Tyrosine Kinase

Natural Killer Cells

Top Venues

Cancer research

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Debarati Mukherjee, Rebecca Ann Previs, Corinne N Haines, Muthana Al Abo, Patrick K Juras, Kyle C Strickland, Binita Chakraborty, Sandeep Artham, Regina S Whitaker, Katherine Hebert, Jake Fontenot, Steven R Patierno, Jennifer A Freedman, Frank H Lau, Matthew E Burow, Ching-Yi Chang, Donald P McDonnell
Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis. Cancer research (2023)
Patrick K Juras, Luigi Racioppi, Debarati Mukherjee, Sandeep Artham, Xia Gao, Laura Akullian D'Agostino, Ching-Yi Chang, Donald P McDonnell
Increased CaMKK2 expression is an adaptive response that maintains the fitness of tumor-infiltrating natural killer cells. Cancer immunology research (2022)
Luigi Racioppi, Erik Russell Nelson, Wei Huang, Debarati Mukherjee, Scott A Lawrence, William Lento, Anna Maria Masci, Yiquin Jiao, Sunghee Park, Brian York, Yaping Liu, Amy E Baek, David Harold Drewry, William J Zuercher, Francesca Romana Bertani, Luca Businaro, Joseph Geradts, Allison Hall, Anthony R Means, Nelson Chao, Ching-Yi Chang, Donald P McDonnell
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. Nature communications 10 (1) (2019)